vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Shutterstock, Inc. (SSTK). Click either name above to swap in a different company.

Shutterstock, Inc. is the larger business by last-quarter revenue ($220.2M vs $205.4M, roughly 1.1× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -7.3%, a 15.5% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -12.0%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $25.9M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 1.4%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Shutterstock, Inc. is an American provider of stock photography, stock footage, stock music, and editing tools; it is headquartered in New York. Founded in 2002 by programmer and photographer Jon Oringer, Shutterstock maintains a library of around 200 million royalty-free stock photos, vector graphics, and illustrations, with around 10 million video clips and music tracks available for licensing. Originally a subscription site only, Shutterstock expanded beyond subscriptions into à la carte p...

COLL vs SSTK — Head-to-Head

Bigger by revenue
SSTK
SSTK
1.1× larger
SSTK
$220.2M
$205.4M
COLL
Growing faster (revenue YoY)
COLL
COLL
+24.9% gap
COLL
12.9%
-12.0%
SSTK
Higher net margin
COLL
COLL
15.5% more per $
COLL
8.3%
-7.3%
SSTK
More free cash flow
COLL
COLL
$96.5M more FCF
COLL
$122.4M
$25.9M
SSTK
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
1.4%
SSTK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
SSTK
SSTK
Revenue
$205.4M
$220.2M
Net Profit
$17.0M
$-16.0M
Gross Margin
62.5%
55.8%
Operating Margin
29.6%
-1.1%
Net Margin
8.3%
-7.3%
Revenue YoY
12.9%
-12.0%
Net Profit YoY
35.3%
-1021.0%
EPS (diluted)
$0.48
$-0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
SSTK
SSTK
Q4 25
$205.4M
$220.2M
Q3 25
$209.4M
$260.1M
Q2 25
$188.0M
$267.0M
Q1 25
$177.8M
$242.6M
Q4 24
$181.9M
$250.3M
Q3 24
$159.3M
$250.6M
Q2 24
$145.3M
$220.1M
Q1 24
$144.9M
$214.3M
Net Profit
COLL
COLL
SSTK
SSTK
Q4 25
$17.0M
$-16.0M
Q3 25
$31.5M
$13.4M
Q2 25
$12.0M
$29.4M
Q1 25
$2.4M
$18.7M
Q4 24
$12.5M
$-1.4M
Q3 24
$9.3M
$17.6M
Q2 24
$19.6M
$3.6M
Q1 24
$27.7M
$16.1M
Gross Margin
COLL
COLL
SSTK
SSTK
Q4 25
62.5%
55.8%
Q3 25
61.7%
60.6%
Q2 25
57.7%
60.3%
Q1 25
54.8%
58.4%
Q4 24
54.0%
55.1%
Q3 24
60.8%
58.3%
Q2 24
62.5%
58.5%
Q1 24
63.1%
58.8%
Operating Margin
COLL
COLL
SSTK
SSTK
Q4 25
29.6%
-1.1%
Q3 25
29.7%
12.5%
Q2 25
18.7%
13.0%
Q1 25
12.2%
4.2%
Q4 24
20.9%
5.3%
Q3 24
21.9%
7.2%
Q2 24
32.7%
9.4%
Q1 24
34.1%
7.8%
Net Margin
COLL
COLL
SSTK
SSTK
Q4 25
8.3%
-7.3%
Q3 25
15.0%
5.1%
Q2 25
6.4%
11.0%
Q1 25
1.4%
7.7%
Q4 24
6.9%
-0.6%
Q3 24
5.9%
7.0%
Q2 24
13.5%
1.6%
Q1 24
19.1%
7.5%
EPS (diluted)
COLL
COLL
SSTK
SSTK
Q4 25
$0.48
$-0.47
Q3 25
$0.84
$0.37
Q2 25
$0.34
$0.82
Q1 25
$0.07
$0.53
Q4 24
$0.36
$-0.04
Q3 24
$0.27
$0.50
Q2 24
$0.52
$0.10
Q1 24
$0.71
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
SSTK
SSTK
Cash + ST InvestmentsLiquidity on hand
$386.7M
$178.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$581.0M
Total Assets
$1.7B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
SSTK
SSTK
Q4 25
$386.7M
$178.2M
Q3 25
$285.9M
$165.5M
Q2 25
$222.2M
$116.4M
Q1 25
$197.8M
$112.2M
Q4 24
$162.8M
$111.3M
Q3 24
$120.0M
$131.4M
Q2 24
$271.6M
$74.9M
Q1 24
$318.0M
$71.8M
Stockholders' Equity
COLL
COLL
SSTK
SSTK
Q4 25
$301.7M
$581.0M
Q3 25
$274.8M
$594.4M
Q2 25
$232.2M
$586.2M
Q1 25
$234.4M
$547.2M
Q4 24
$228.8M
$518.4M
Q3 24
$234.3M
$522.9M
Q2 24
$216.6M
$520.4M
Q1 24
$222.2M
$541.3M
Total Assets
COLL
COLL
SSTK
SSTK
Q4 25
$1.7B
$1.4B
Q3 25
$1.6B
$1.4B
Q2 25
$1.6B
$1.4B
Q1 25
$1.6B
$1.3B
Q4 24
$1.7B
$1.3B
Q3 24
$1.6B
$1.3B
Q2 24
$1.1B
$1.0B
Q1 24
$1.1B
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
SSTK
SSTK
Operating Cash FlowLast quarter
$123.0M
$36.2M
Free Cash FlowOCF − Capex
$122.4M
$25.9M
FCF MarginFCF / Revenue
59.6%
11.8%
Capex IntensityCapex / Revenue
0.3%
4.7%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$123.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
SSTK
SSTK
Q4 25
$123.0M
$36.2M
Q3 25
$78.4M
$78.4M
Q2 25
$72.4M
$26.8M
Q1 25
$55.4M
$25.2M
Q4 24
$84.6M
$8.0M
Q3 24
$-9.0M
$-11.6M
Q2 24
$67.4M
$28.0M
Q1 24
$61.9M
$8.3M
Free Cash Flow
COLL
COLL
SSTK
SSTK
Q4 25
$122.4M
$25.9M
Q3 25
$78.3M
$68.0M
Q2 25
$72.4M
$15.5M
Q1 25
$54.6M
$14.4M
Q4 24
$84.1M
$-952.0K
Q3 24
$-9.2M
$-26.3M
Q2 24
$67.1M
$18.9M
Q1 24
$61.4M
$-6.2M
FCF Margin
COLL
COLL
SSTK
SSTK
Q4 25
59.6%
11.8%
Q3 25
37.4%
26.1%
Q2 25
38.5%
5.8%
Q1 25
30.7%
6.0%
Q4 24
46.2%
-0.4%
Q3 24
-5.8%
-10.5%
Q2 24
46.2%
8.6%
Q1 24
42.3%
-2.9%
Capex Intensity
COLL
COLL
SSTK
SSTK
Q4 25
0.3%
4.7%
Q3 25
0.1%
4.0%
Q2 25
0.0%
4.2%
Q1 25
0.4%
4.5%
Q4 24
0.3%
3.6%
Q3 24
0.2%
5.9%
Q2 24
0.2%
4.1%
Q1 24
0.4%
6.7%
Cash Conversion
COLL
COLL
SSTK
SSTK
Q4 25
7.25×
Q3 25
2.49×
5.86×
Q2 25
6.05×
0.91×
Q1 25
22.92×
1.35×
Q4 24
6.75×
Q3 24
-0.96×
-0.66×
Q2 24
3.44×
7.71×
Q1 24
2.23×
0.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons